Delivery Order SPE2DB25D3108-SPE2DB26FPBMQ
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for Multaq 400 mg tablets (60-count units) valued at $4,589.64. The contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a competitively awarded transaction under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $1,025.26. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,422.22 by the Defense Logistics Agency on July 14, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract is classified as a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Multaq 400 mg tablets (60-count packages) valued at $11,622.61. This competitively awarded, firm fixed-price delivery order is set to be completed by October 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $11,497.10 firm fixed price delivery order by the Defense Department's Medical Supply Chain on September 12, 2025, for 60 tablets of Multaq 400mg. The award was made competitively with no set-aside designation and has an ultimate completion date of October 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,155.04 by the Defense Logistics Agency on September 4, 2025, for the supply of 60 tablets of Multaq 400 mg. The award is a firm fixed-price contract with no set-aside designation, and performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,697.14 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, which is a non-set-aside competitive award, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. Performance will take place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $24,960.51 with firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by September 15, 2025, with performance of work occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $39,351.89. This competitive, non-set-aside award utilizes firm fixed-price pricing and is expected to be completed by September 19, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $1,959.09. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a non-competitive procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this order from its...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB26FPBMQDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order (Contract No. 4569889035) by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of Multaq 400 mg tablets (60-count packages) at a ceiling value of $2,162.78. The contract carries a firm fixed price structure with an ultimate completion date of November 3, 2025, and represents a competitive award with no set-aside designation. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to the Department of Defense healthcare systems globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp maintains a substantial portfolio of delivery orders with the DLA covering a diverse range of medications and medical commodities. The DLA Troop Support Medical IDC enables the company to fulfill requirements across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, and other federal healthcare entities. This specific delivery order for Multaq, an antiarrhythmic medication, reflects the company's role in supplying critical pharmaceutical products necessary for military medical readiness and veteran healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/31/25 |